Table 3

Inhibition of BFC debenzylase activity

CompoundCalculated Molecular VolumeMolecular WeightEstimatedKiKi Ratio
Wild Type (WT)L211FL211YL211F/WTL211Y/WT
Diazepam24228580  ± 2371  ± 775  ± 50.90.9
Nifedipine2923463.0  ± 1.67  ± 23.4  ± 0.82.21.1
Diltiazem29845118  ± 433  ± 332  ± 31.81.8
Progesterone31231555  ± 1257  ± 261  ± 91.01.1
Haloperidol3323769.0  ± 0.810  ± 123  ± 51.12.5
Verapamil43745512  ± 214  ± 225  ± 31.22.1
Bromocriptine5516570.31  ± 0.060.45  ± 0.050.41  ± 0.101.51.3
Erythromycin68173421  ± 0.642  ± 5147  ± 112.07.1
Vinblastine7428111.5  ± 0.418  ± 135  ± 412.023.0
Troleadomycin7518141.1  ± 0.313  ± 346  ± 313.043.0
Cyclosporin A116412010.14  ± 0.041.5  ± 0.23.2  ± 0.811.023.0

Calculated molecular volumes are in Å3, molecular weights in grams per mole, and estimated Kl values are in micromolar concentration. Sample profiles from this data set are shown in Fig. 2.